Evidence map›Paper›PMID 39058404›Full record

ArticleBiochemical genetics2025

Familial Episodic Pain Syndrome: A Japanese Family Harboring the Novel Variant c.2431C>T (p.Leu811Phe) in SCN11A.

Chioko Nagao, Hiroko Okuda, Gert-Jan Bekker, Atsuko Noguchi, Tsutomu Takahashi, Akio Koizumi, Shohab Youssefian, Tohru Tezuka, Shinji Akioka

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chioko Nagao *Institute for Protein Research, Osaka University, Osaka, Japan.
Hiroko Okuda *Department of Pain Pharmacogenetics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Gert-Jan BekkerInstitute for Protein Research, Osaka University, Osaka, Japan.
Atsuko NoguchiDepartment of Pediatrics, Akita University School of Medicine, Akita, Japan.
Tsutomu TakahashiDepartment of Pediatrics, Akita University School of Medicine, Akita, Japan.
Akio KoizumiDepartment of Pain Pharmacogenetics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shohab YoussefianDepartment of Pain Pharmacogenetics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tohru TezukaDepartment of Pain Pharmacogenetics, Graduate School of Medicine, Kyoto University, Kyoto, Japan. tezuka.toru.8w@kyoto-u.ac.jp.
Shinji Akioka *Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. sakioka@koto.kpu-m.ac.jp.

Funding

Grand-in-Aid for Scientific Research from the Japan Society for the Promotion of Science JP20H03229MHLW Research on the Rare and Intractable diseases Program JPMH19FC1003MHLW Research on the Rare and Intractable diseases Program JPMH22FC1006
6 · The paper itself

Abstract

Familial episodic pain syndrome (FEPS) is an autosomal-dominant inherited disorder characterized by paroxysmal pain episodes. FEPS appears in early childhood, gradually disappearing with age, and pain episodes can be triggered by fatigue, bad weather, and cold temperatures. Several gain-of-function variants have been reported for SCN9A, SCN10A, or SCN11A, which encode the voltage-gated sodium channel α subunits Nav1.7, Nav1.8, and Nav1.9, respectively. In this study, we conducted genetic analysis in a four-generation Japanese pedigree. The proband was a 7-year-old girl, and her brother, sister, mother, and grandmother were also experiencing or had experienced pain episodes and were considered to be affected. The father was unaffected. Sequencing of SCN9A, SCN10A, and SCN11A in the proband revealed a novel heterozygous variant of SCN11A: g.38894937G>A (c.2431C>T, p.Leu811Phe). This variant was confirmed in other affected members but not in the unaffected father. The affected residue, Leu811, is located within the DII/S6 helix of Nav1.9 and is important for signal transduction from the voltage-sensing domain and pore opening. On the other hand, the c.2432T>C (p.Leu811Pro) variant is known to cause congenital insensitivity to pain (CIP). Molecular dynamics simulations showed that p.Leu811Phe increased the structural stability of Nav1.9 and prevented the necessary conformational changes, resulting in changes in the dynamics required for function. By contrast, CIP-related p.Leu811Pro destabilized Nav1.9. Thus, we speculate that p.Leu811Phe may lead to current leakage, while p.Leu811Pro can increase the current through Nav1.9.

Indexed as

PainChildEast Asian PeopleFemaleHumansJapanMaleNAV1.7 Voltage-Gated Sodium ChannelNAV1.9 Voltage-Gated Sodium ChannelPedigreeNAV1.7 Voltage-Gated Sodium ChannelNAV1.9 Voltage-Gated Sodium ChannelSCN11A protein, humanSCN9A protein, humanFamilial episodic pain syndromeMolecular dynamicsNav1.9SCN11A gene

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.